Market Cap 3.41M
Revenue (ttm) 0.00
Net Income (ttm) -9.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 45,600
Avg Vol 3,281,406
Day's Range N/A - N/A
Shares Out 2.47M
Stochastic %K 86%
Beta 0.65
Analysts Strong Sell
Price Target $10.00

Latest News on ENVB

Enveric Biosciences Participating in BIO-Europe Spring®

Mar 17, 2025, 1:40 PM EDT - 5 weeks ago

Enveric Biosciences Participating in BIO-Europe Spring®


Enveric Biosciences CEO Issues Letter to Shareholders

Feb 27, 2025, 9:30 AM EST - 2 months ago

Enveric Biosciences CEO Issues Letter to Shareholders


Enveric Biosciences Announces Broad Range of Patent Issuances

Nov 4, 2024, 10:36 AM EST - 6 months ago

Enveric Biosciences Announces Broad Range of Patent Issuances


Enveric Biosciences Announces Patent Granted for Drug Candidate

Jul 10, 2024, 8:00 AM EDT - 10 months ago

Enveric Biosciences Announces Patent Granted for Drug Candidate